A Mixed-methods Evaluation of an Adapted Acceptance and Commitment Therapy (ACT) Group for Stroke Survivors

NCT03295032 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2017-09-27

No results posted yet for this study

Summary

Stroke is one of the main causes of acquired adult disability in the UK. Many psychological problems can also occur post-stroke; this has a marked impact on health service usage. As such, there is an outstanding need to increase and improve psychological resources within stroke services.

The investigators proposed to adapt and evaluate the effectiveness of an acceptance and commitment therapy (ACT) group intervention for adult stroke survivors and their carers. The group will endeavour to promote positive adjustment and reduce levels of depression and anxiety.

This study will have two parts.

Conditions

  • Stroke
  • Acceptance and Commitment Therapy

Interventions

BEHAVIORAL

Acceptance and Commitment Therapy (ACT)

ACT is a psychological intervention; in this study it is being delivered as a 4-week psycho-educational group to stroke survivors and carers. Rather than attempting to control or ameliorate pain and suffering, ACT advocates that individuals remain open to internal private experiences (both positive and negative) and should focus on committing to a life which is congruent with their core values. Individuals learn to modify their relationship with these experiences, rather than change the experiences per se through processes such as mindfulness, acceptance and attention to values. This fundamental premise of ACT helps cultivate psychological flexibility.

Sponsors & Collaborators

  • Cwm Taf University Health Board (NHS)

    collaborator OTHER_GOV
  • Cardiff and Vale University Health Board

    collaborator OTHER_GOV
  • Aneurin Bevan University Health Board

    collaborator OTHER
  • North Bristol NHS Trust

    collaborator OTHER
  • University Hospitals Bristol and Weston NHS Foundation Trust

    collaborator OTHER
  • BASF

    collaborator INDUSTRY
  • Cardiff University

    lead OTHER

Principal Investigators

  • Professor Reg Morris, PhD · Cardiff University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2016-12-29
Completion
2016-12-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03295032 on ClinicalTrials.gov